Thus, it seems plausible that the high levels of IL-1β in PCC reflect this protective role and that post-infection vaccination provides a sufficient refinement of the SARS-CoV-2-directed immune response to clear persisting viral antigens, at least in a subset of PCC patients. The gene discussed is IL1B; the disease is infection.